Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Royalty Pharma plc publishes a filing, an earnings call transcript or a press release.

Get RPRX alerts

About Gregory Norden

Gregory Norden is recorded as CFO at Royalty Pharma plc (RPRX) and Board Member at Praxis Precision Medicines, Inc. (PRAX) since January 1, 2019. The newest filing on record that lists Gregory Norden as CFO at Royalty Pharma plc (RPRX) is dated April 10, 2026. The newest filing on record that lists Gregory Norden as Board Member at Praxis Precision Medicines, Inc. (PRAX) is dated April 30, 2026. Praxis Precision Medicines, Inc. is classified in the Biotechnology industry within the Healthcare sector. Royalty Pharma plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Praxis Precision Medicines, Inc. includes Marcio Souza (CEO and Board Member), Timothy E. Kelly (CFO), Timothy Kelly (CFO) and 6 others.

Affiliation history

Company network

Leadership on record at Praxis Precision Medicines, Inc.

Leadership on record at Royalty Pharma plc

Recent activity

No call appearances or filed executive changes recorded yet.